Perrigo Company plc (PRGO)
| Market Cap | 2.01B -38.9% |
| Revenue (ttm) | 4.14B -4.2% |
| Net Income | -1.73B |
| EPS | -12.49 |
| Shares Out | 138.77M |
| PE Ratio | n/a |
| Forward PE | 6.31 |
| Dividend | $1.16 (8.01%) |
| Ex-Dividend Date | Aug 28, 2026 |
| Volume | 2,604,344 |
| Open | 14.09 |
| Previous Close | 14.08 |
| Day's Range | 14.00 - 14.57 |
| 52-Week Range | 9.23 - 23.98 |
| Beta | 0.54 |
| Analysts | Buy |
| Price Target | 16.50 (+13.95%) |
| Earnings Date | Aug 5, 2026 |
About PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai... [Read more]
Financial Performance
In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price target is $16.5, which is an increase of 13.95% from the latest price.
News
Perrigo to Attend the Barclays Global Consumer Conference
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo...
Perrigo Company Transcript: Canaccord Genuity's 46th Annual Growth Conference
Operating in a resilient €400B market, the company is executing a 3S transformation plan, simplifying its portfolio, and leveraging a category-led model to drive innovation and market share. E-commerce is accelerating, and structural improvements are expected to deliver growth and margin gains.
Perrigo Company Slides: Canaccord Genuity's 46th Annual Growth Conference
Perrigo Company has posted slides in relation to its latest quarterly earnings report, which was published on August 12, 2026.
Perrigo Company Earnings Call Transcript: Q2 2026
Second quarter results showed a 3.1% year-over-year decline in core net sales, but market share gains in both U.S. and Europe, driven by innovation and improved execution. Full-year 2026 outlook is reaffirmed, with sequential improvement expected in the second half.
Perrigo Company Earnings release: Q2 2026
Perrigo Company released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Perrigo Company Slides: Q2 2026
Perrigo Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Perrigo Company Quarterly report: Q2 2026
Perrigo Company has published its Q2 2026 quarterly earnings report on August 5, 2026.
Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
Execution of Three-S plan driving continued improvement in underlying business fundamentals, including market share growth in U.S. store-brand OTC and key European brands Streamlined portfolio through...
Perrigo Announces Quarterly Dividend
DUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend...
Perrigo to Present at the Canaccord 46th Annual Growth Conference
DUBLIN, July 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo...
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its second quarter 2026 financial re...
Perrigo appoints Salman Amin and Omer Gajial as independent directors
Perrigo (PRGO) Company announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent directors, effective June 30. Amin is an experienced executive with more than…
Perrigo Announces Appointment of Two New Independent Directors to Board
DUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Ami...
Perrigo rumor highlighted in Betaville blog
A rumor regarding Perrigo (PRGO) was highlighted in Ben Harrington’s takeover-focused Betaville blog, contacts tell The Fly.
Perrigo CEO Ousted Over Personal Conduct
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
Perrigo says Albert Manzone appointed interim President and CEO
Perrigo (PRGO) announced that its Board of Directors has appointed Albert Manzone, a member of the company’s Board, as Interim President and CEO, effective immediately. The Board has initiated a…
Perrigo Announces Leadership Transition
Albert A. Manzone Appointed Interim President and CEO Patrick Lockwood-Taylor Resigns as President and CEO and as a Member of the Board DUBLIN, June 8, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: ...
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
DUBLIN, May 26, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Be...
Perrigo reports Q1 EPS 43c, consensus 31c
Reports Q1 revenue $969.2M, consensus $1.04B. “Our first quarter results reflect tangible progress as we continue to transform Perrigo (PRGO) into a more focused, disciplined, and consistent business,...
Perrigo reports Q1 EPS 43c, consensus 31c
Reports Q1 revenue $969.2M, consensus $1.04B. “Our first quarter results reflect tangible progress as we continue to transform Perrigo (PRGO) into a more focused, disciplined, and consistent business,...
Perrigo Company Earnings Call Transcript: Q1 2026
First quarter 2026 saw sales and margins pressured by weak cough/cold demand and retailer destocking, but market share gains and cost savings supported results. Full-year guidance is reaffirmed, with improvement expected in the second half as headwinds ease.
Perrigo Company Earnings release: Q1 2026
Perrigo Company released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Perrigo Company Slides: Q1 2026
Perrigo Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Perrigo Company Quarterly report: Q1 2026
Perrigo Company has published its Q1 2026 quarterly earnings report on May 6, 2026.
Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations
Mitigating category headwinds with market share gains through implementation of Three‑S plan. Specialty Care segment achieved net sales and segment operating income growth, led by continued momentum i...